The Estradiol Patch Shortage: What Women in Perimenopause and Menopause Need to Know
If you've called your pharmacy recently to refill an estradiol patch and been told it's backordered, you're far from alone. Patients across the country, have run into the same issues this year. Here's what's actually going on, why it's happening now, and what to do if it affects you.
Is there really a shortage?
The honest answer is: it depends who you ask. The American Society of Health-System Pharmacists (ASHP), the group that most pharmacies and hospitals rely on for real-world supply tracking, has listed estradiol transdermal patches as being in shortage since January 2026, with more than a dozen specific patch products from multiple manufacturers on back order or allocation as of this summer. The FDA, by contrast, has not added estradiol patches to its own official shortage database, and says all six U.S. manufacturers report running at full capacity.
That disconnect comes down to methodology. ASHP's data is built from pharmacists reporting what they can't get on their shelves. The FDA's threshold is different, as it only counts a true "shortage" when manufacturers themselves can't meet overall national demand, which is a much harder bar to clear. So two reputable organizations can look at the same reality and describe it differently. What this means for patients is that you may be told your usual brand or strength is unavailable, even though there's technically no federal shortage declaration.
Why is this happening now?
This shortage is, in a strange way, good news turned into a supply problem. In November 2025, the FDA and HHS moved to remove the boxed warning that had been on menopausal hormone therapy labels for years. This language that had discouraged both patients and prescribers from considering these medications, often even when appropriate. Once that warning started coming off the labels in early 2026, demand surged. Some estimates put prescription growth for estrogen-based hormone therapy in women aged 45–54 at roughly double 2023 levels. Manufacturers, several of whom make these patches using specialized equipment that isn't quick to scale, have been racing to catch up ever since.
In other words, more women are finally getting connected to a treatment that's long been underused and supply hasn't caught up yet.
Why estradiol matters for perimenopause and menopause
Estrogen hormone therapy is considered the most effective treatment available for hot flashes and night sweats, according to the American College of Obstetricians and Gynecologists. The North American Menopause Society's most recent position statement reinforces this: for healthy women younger than 60, or within 10 years of menopause onset, who don't have contraindications, the benefits of hormone therapy for symptom relief and bone protection generally outweigh the risks. Beyond vasomotor symptoms, hormone therapy has also been shown to reduce the risk of bone loss and fracture, a benefit that often goes overlooked in conversations focused only on hot flashes.
That's part of why this shortage is landing hard. For many women, an estradiol patch isn't a minor convenience. It is what is keeping sleep, mood, and daily functioning on track during a transition that can otherwise be genuinely debilitating.
What to do if you're affected
If your regular patch is unavailable, you're not without options, and you don't have to go without treatment:
Call us before panicking or going without. Our care team can often help find which strength or brand is currently in stock at your pharmacy, or submit a new prescription if a switch is needed.
Ask about alternative delivery methods. Estradiol gel and spray work the same way patches do, absorbed through the skin, bypassing the liver and are reasonable substitutes if patch supply or adhesive issues are the obstacle.
Don't assume all brands are equally affected. Because the shortage is uneven across manufacturers and strengths, a different brand of the same patch may be available even when your usual one isn't.
Avoid compounded or unregulated alternatives without talking to us first. It can be tempting to look for workarounds online, but compounded hormone products aren't FDA-regulated in the same way, and dosing can be inconsistent. We work with local, trusted compounding pharmacies to meet our patient’s needs.
Our commitment
We know this shortage has added one more layer of frustration to a stage of life that can inherently feel overwhelming. Our team is actively tracking supply issues and working with local pharmacies to help our patients stay on treatment with as little disruption as possible. If you're navigating perimenopause or menopause and have questions about hormone therapy, whether you're starting it for the first time or trying to work around a supply gap, we are here to support you. You shouldn't have to manage this alone.
__________________
Sources: American Society of Health-System Pharmacists (ASHP) Drug Shortage Bulletin, estradiol transdermal systems; U.S. Food and Drug Administration statements on estradiol patch supply (2026); NBC News, "Estrogen patches are hard to find"; American College of Obstetricians and Gynecologists (ACOG); North American Menopause Society (NAMS), 2022 Hormone Therapy Position Statement.